small molecule

HEMANGEOL

PROPRANOLOL HYDROCHLORIDE

Loss of exclusivityOctober 2028latest FDA-listed patent expiry
CompanyEton PharmaceuticalsView the full company profile on CliffBio

Drug detail

Brand nameHEMANGEOL
Active ingredientPROPRANOLOL HYDROCHLORIDE
Strength4.28MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2014
Marketing statusRX

Listed patents

PatentExpiresType
8338489October 2028use U-1496
8987262October 2028use U-1988

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

HEMANGEOL patent cliff — loss of exclusivity October 2028 | CliffBio